Juvenile macular degeneration is a genetic eye disorder that causes progressive vision loss. This disorder affects the retina, the specialized light-sensitive tissue that lines the back of the eye. Specifically, juvenile macular degeneration affects a small area near the center of the retina called the macula. The macula is responsible for sharp central vision, which is needed for detailed tasks such as reading, driving, and recognizing faces. The market is mainly driven by factors such as the increasing prevalence of eye disorders, development of new drugs and therapies, and emerging government policies. However, the high cost of treatment and lack of reimbursement is expected to restrain the growth of this market.
uvenile Macular Degeneration Market China and India contribute to the growth of the market. On the other hand, the Middle East & Africa hold the least share of the market due to the low prevalence of macular degeneration in the region and limited availability of funds and availability of medical facilities. The Middle East has a huge share for the Juvenile Macular Degeneration Market due to the presence of well-developed countries like Kuwait, Qatar, Oman and Saudi Arabia. However, due to the presence of a huge opportunity for the development of the market, Africa region is expecting a healthy growth in near future. Global Juvenile Macular Degeneration (Stargardt Disease) market is expected to grow at a CAGR of 7.2% during the forecast period 2017-2023.
Sample Report: https://www.marketresearchfuture.com/sample_request/4935
Key Players in Global Juvenile Macular Degeneration Market Acucela Inc. (U.S.), Alkeus Pharmaceuticals Inc. (U.S.), Astellas Pharma Inc. (Japan), ProQR Therapeutics NV (Netherland), Sanofi (France), Bayer HealthCare (Germany), F. Hoffmann-La Roche (Switzerland), Copernicus Therapeutics Inc. (U.S.), Grupo Ferrer Internacional SA (U.S.), Iris Pharma (U.S.), Nemus Bioscience Inc (U.S.), Ophthotech Corp (U.S.), Iconic Therapeutics (U.S.), Adverum Biotechnologies (U.S.), PanOptica (U.S.), RXi Pharmaceuticals (U.S.), Neurotech Pharmaceuticals (U.S.)
The European juvenile macular degeneration market accounted for 32.7% market share in 2016. In Europe, Germany, the U.K, and France are the largest contributors to the market owing to the availability of funds for research, and extensive research and development activities in ophthalmology. The development of novel therapies and other treatment options for juvenile macular degeneration also fuel the growth of the market. The Middle East & Africa exhibit steady but positive growth owing to low technology penetration in developing regions of Africa, and increasing demand for diagnostics services in developing regions. In the Middle East, the United Arab Emirates accounts for the largest market share for macular degeneration.
READ MORE @ https://www.marketresearchfuture.com/reports/juvenile-macular-degeneration-market-4935
Medical Digital Imaging Devices Market Research Report - Global Forecast till 2027
Atorvastatin API Market Research Report - Global Forecast till 2027
Pharmacy Benefit Management Services Market Research - Global Forecast 2027
About Us: Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
Lorsqu'il s'agit de développer votre entreprise, l'externalisation est un must, et collaborer avec des spécialistes qui peuvent apporter de la valeur à votre marque est une sage décision à prendre. Comment ..
As a world woman, you're self-sufficient; you know what you want and go after it. You don't wait for things to come to you, whether it's a wonderful career, a spectacular vacation, or an outstanding apartment. ..
Overview Hemoglobinopathies are also known as hemoglobinopathy. It is the medical term referred to the group of blood disorders and diseases that affect red blood cells. Hemoglobinopathies are inherited ..
When businesses are asked to do more with less, cost optimization, a foundational responsibility for sourcing and procurement leaders in the supply chain, becomes much more essential. Now is the time to ..
Global Automatic Pill Dispenser Market Research Report: Information by Type (Centralized Automated Dispensing System, Decentralized Automated Dispensing System), End User (Hospital Pharmacy, Retail Pharmacy, ..